Lawton Alison Frances 4
4 · X4 Pharmaceuticals, Inc · Filed Oct 6, 2020
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (right to buy)
2020-10-05+6,854→ 6,854 totalExercise: $7.33Exp: 2030-10-04→ Common Stock (6,854 underlying)
Footnotes (1)
- [F1]33.3333% of the shares subject to the option shall vest on October 5, 2021, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.